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A simple system for high yield expression of the 
neurospora  plasma  membrane  H+-ATPase is described. 
Two neurospora H+-ATPase cDNAs differing only in a 
few  bases  preceding  the  coding  region  were  cloned  into 
a  high  copy  number  yeast  expression  vector  under  the 
control  of  the  constitutive  promoter  of  the  yeast  plasma 
membrane  H+-ATPase,  and  the  resulting  plasmids  were 
used  to  transform Saccharomyces cerevisiae strain RS- 
72, which  requires  a  plasmid-borne  functional  plasma 
membrane H+-ATPase for growth in glucose medium 
(Villalba, J. M., Palmgren, M. G., Berberian, G. E., 
Ferguson, C., and  Serrano, R. (1992) J. BioZ. Chem. 267, 
12341-12349. Both plasmids supported growth of the 
cells, indicating that the neurospora ATPase is ex- 
pressed in functional form in yeast. Western blots of 
membranes  from the  transformants  confirmed  that  the 
neurospora  ATPase is expressed  in  the  yeast  cells,  with 
production in the  range of several  percent  of  the  yeast 
membrane  protein.  Importantly,  when  the  expressed,  re- 
combinant neurospora ATPase molecules are solubi- 
lized from the membranes with lysolecithin and sub- 
jected  to  glycerol  gradient  centrifugation,  they  migrate 
to  a  position  indistinguishable from  that  of  the  native 
ATPase  and display  a  comparable  specific  ATPase activ- 
ity,  indicating  that  the  great  majority  of  the  recombi- 
nant  neurospora  ATPase  molecules  produced  in  yeast 
fold  in  a  natural  manner.  This  expression  system  thus 
appears  to  be  ideal  for  site-directed  mutagenesis  studies 
of the  neurospora  ATPase  molecule. 
The Neurospora crassa plasma membrane H+-ATPase was 
identified biochemically more than a  decade ago (1,2)  and since 
that time  has become one of the  most thoroughly studied mem- 
bers of the transport ATPase family known as the P-type 
ATPases (3). Several reviews  chronicling this progress with  the 
N. crassa H+-ATPase are  available (4-6) as  are reviews of the 
comparable progress that has occurred with  the closely related 
yeast  and  plant  plasma  membrane H+-ATPases (4, 7, 8). The 
result of all of this  experimental  attention  is a reasonably thor- 
ough understanding of the biochemical and  transport proper- 
ties of the  fungal  and  plant  P-type H+-ATPases. 
The  next  important goal in this field is an  understanding of 
the molecular mechanism by which these ATPases catalyze 
ATP hydrolysis-driven ion translocation. Unfortunately, de- 
spite  the  wealth of biochemical information  available for these 
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transport enzymes, we still know very  little  about how they 
really work. As is elegantly  manifest  in  the  important work of 
Fersht  and his collaborators (9-111, in order  to  understand how 
e zymes work it is  necessary  to know their molecular structure 
in fine detail and to then define the specific functions of a 
variety of individual  amino acid residues  in  the molecule, which 
is most  rigorously  done by site-directed  mutagenesis.  This  re- 
quires the ability to grow diffraction quality crystals of the 
enzyme and  the  availability of an effective system for express- 
ing forms of the enzyme with specifically altered  residues. Al- 
though  several effective expression systems for the  yeast  and 
plant H+-ATPases have been  described (12-151, to  our knowl- 
edge  no crystals of these enzymes are  as  yet available. On  the 
other  hand, a procedure for obtaining  large, single, three-di- 
mensional crystals of the N. crassa H+-ATPase has been devel- 
oped (16), but a suitable expression system for this enzyme has 
not heretofore been reported. In this article, we describe an 
efficient system for expressing recombinant forms of the N. 
crassa H+-ATPase in  yeast  and methodology for assessing  the 
effects of specific mutations on the  ability of the  recombinant 
ATPase molecules to properly fold and catalyze ATP hydrolysis. 
The availability of this new expression system and the H+- 
ATPase crystals will hopefully provide a foundation  for the  next 
generation of efforts to  understand  the molecular structure  and 
mechanism of this  interesting  membrane  transport enzyme. 
EXPERIMENTAL PROCEDURES 
Plasmid Constructions-Standard  recombinant DNA techniques (17) 
were  used to construct  plasmids  containing  the  N.  crassa  plasma  mem- 
brane H+-ATPase  cDNAfor  expression in Saccharomyces  cerevisiae.  The 
path to the  final  products  was  not  entirely  direct as it proceeded  via 
different  types of expression  plasmid,  each of which  was  tried in its 
appropriate host cell. Unless indicated otherwise, site-directed mu- 
tagenesis was performed in M13 vectors according to the method of 
Kunkel (18). We began  with the plasmid  pSPM8,  which contains  the 
full-length cDNA for the N. crassa H+-ATPase (19). The  EcoRI site in the 
3”untranslated region of the ATPase cDNA was  removed by performing 
a partial digest of pSPM8 with EcoRI, filling in  the  ends  with DNA 
polymerase  “Klenow” fragment,  and  religating in the presence of PstI 
linkers. An NdeI site (CATATG)  was then introduced at the beginning of 
the coding  sequence  encompassing the ATG start codon. Silent  restric- 
tion sites forXbaI, SmaI, and  Sac1  were  also  introduced  by  mutagenesis 
at positions  1237,  1777,  and  2158 of the coding  sequence,  respectively. 
The  NdeI-PstI fragment was then subcloned  into the plasmid  pT7-7, 
one of the T7  promoter  expression  plasmids of Tabor  and  Richardson 
(201,  to  yield  pT7-7/HANF’.  The  H+-ATPase cDNA was then cloned  into 
the baculovirus transfer vector pVL1393. Plasmid pT7-7/HANP was 
digested  with  NdeI,  the  ends  filled  in  with  Klenow  fragment,  and then 
digested  with  PstI.  The cDNA fragment was then ligated  into pVL1393 
digested  with SmaI and PstI. This construct, pVL1393NSA3,  contains 
the coding  region of the H+-ATPase as a BamHI  (from the poly1inker)- 
PstI fragment. At this point,  the  H+-ATPase cDNA was  sequenced  in its 
entirety by the chain termination procedure (17) to ensure that no 
unexpected mutations  had  occurred. 
The H+-ATPase cDNA was next cloned into the yeast expression 
plasmid  pRS421.  This  plasmid is a derivative of the  yeast expression 
plasmid  YEP351 (21) containing a 1.95-kilobase  Hind111 fragment with 
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the  strong promoter and  termination  regions of the  yeast  PMAl  gene 
separated by a XhoI site, as described  by  Villalba  et al. (15). It contains 
several  upstream  sequences conducive to efficient expression  in  yeast 
(151, as  well as the  LEU2  gene for selection and a  2-pm circle for high 
copy number  replication  (21). To clone the N. crassa ATPase gene  into 
this vector, the BamHI and PstI sites flanking the ATPase gene in 
pVL1393NSA3  were  destroyed by the addition of NotI  linkers  as de- 
scribed above, and  the  resulting 3.15-kilobase fragment  was  ligated  into 
the plasmid  pRS42l-Not,  which had been modified from pRS421 by the 
addition of a NotI  linker at the XhoI  site of the plasmid.  The pRS421- 
Not construct  harboring  the  N.  crassa H+-ATPase cDNA in  the  sense 
direction  was  designated pSKMHA1. 
A  construct  similar  to  pSKMHAl  with  two  adenosines  in place of the 
cytosine a t  position -2 from the ATG start codon of the H+-ATPase was 
also  made. To do this,  the  mutagenic oligonucleotide, 5'-G AGA GGA 
TCC AAT  ATG GCG GAC CAC TCG GC-3' was synthesized. This 
primer, in combination with another primer complementary to the 
sense  strand of the H+-ATPase cDNA near  the  internal EcoRI site,  was 
then used in the polymerase chain reaction with pVL1393LJSA3 as 
template  to  amplify  and  to  introduce  the  changed  bases.  The  BamHI- 
EcoRI polymerase chain reaction-amplified fragment was then sub- 
cloned back  into PVL1393KJSA3 from  which the  normal  BamHI-EcoRI 
fragment  had  been removed. The  plasmid  was  purified by CsCl gradient 
centrifugation,  and  the  successful  mutagenesis  was confirmed by 
dideoxynucleotide sequencing. The mutant 3.15-kilobase BamHI-PstI 
fragment  containing  the H+-ATPase cDNA was  then cloned into 
pRS42l-Not  as  described above. The  resulting  construct  was  designated 
pSKMHA2, and  the corresponding  antisense  construct  was  designated 
S t ra ins   and   MediaS.  cereuisiae strain RS-72 and  transformants 
thereof  were  used  throughout this study. It is MATa, adel-100, his4- 
519, and  leu24112  and  carries  the  yeast  PMAl  gene  under  the control 
of the  galactokinase  gene  (GAM)  promoter (22). Cells  were grown on 
synthetic  medium  containing 2% (w/v) galactose  or glucose and 0.7% 
(w/v) yeast  nitrogen  base  without  amino  acids,  supplemented  with 0.2 
mM adenine,  0.4 mM histidine,  and 1 mM leucine. For the selection  and 
growth of transformants,  the leucine  was  omitted. Solid media  addi- 
tionally  contained 2% (w/v) Difco agar.  For  the  preparation of mem- 
branes,  the  transformants  were grown in galactose  medium  to  station- 
ary  phase  (38-40  h),  diluted 10-fold into  galactose  or glucose media,  and 
allowed to grow for an additional  24  h,  unless  indicated  otherwise.  The 
cells were harvested by centrifugation, washed once with distilled 
water, and  used for the  preparation of membranes  as  described below. 
About 3-5 g  wet  weight of cells was  obtained  per  liter of culture. 
Yeast Dunsformation-Transformation of the  yeast cells was  carried 
out  according  to  the  standard protocol of Ito  et al. (23).  The cells were 
made  competent  using  lithium  acetate  (0.1 M) and polyethylene glycol 
(35%). After transformation,  the  cells  were  plated on galactose  medium 
without  leucine,  and  the  transformants  were  selected  after  4  days of 
growth at 30 "C. Yeast strains SKM1, SKM2, and SKM5 were  derived 
from the  transformation of RS-72 cells with plasmids pSKMHA1, pSK- 
MHA2, and pSKMHA5, respectively. Transformation of strain RS-72 
with  plasmid  pRS42l-Not  (no H+-ATPase cDNA insert)  gave rise to  the 
control strain SKM3. And finally, transformation of strain RS-72 with 
plasmid pPS15P1 (24) containing the yeast PMAl promoter, coding 
sequence, and  termination  regions  in  the low  copy number  expression 
plasmid, pRS315 (251, yielded strain SKM4. 
Growth Tests-Growth of selected  yeast  transformants  was  assessed 
using a drop test similar  to  that  described by Villalba  et al. 115). The 
cells were grown to  stationary  phase on galactose  medium,  and  then 
about lo4 cells in 2  pl  were  spotted  on  agar  plates  containing  either 
galactose or glucose medium. Cell growth  was scored after  72 hat 30 "C. 
To estimate  the colony size and  rate of growth of the  transformants,  the 
same  amount of cells was  streaked on agar  plates  containing  galactose 
or glucose using an  inoculation loop and  the  growth recorded after  72  h 
a t  30 "C. 
Isolation of Membranes-Yeast cells were  harvested by centrifuga- 
tion and washed and resuspended in homogenization buffer as de- 
scribed  by  Serrano  (26),  but on a smaller  scale (0.5-4 g  wet  weight of 
cells). The  resulting cell suspensions  were mixed with 425-600 micron 
acid washed  glass  beads as described (26), and  the cells were  broken in 
a  Bead  Beater (Biospec Products,  Bartlesville, OK) with ice-cold water 
in the upper chamber as a coolant. For 0.5-1 g of cells, 8.5 ml of 
homogenization  buffer  and 17 ml of glass  beads  were  used,  and homog- 
enization  was  carried  out in a  small  Bead  Beater  chamber.  For 2 4  g of 
cells, 8.5  ml of homogenization  buffer and 17 ml of glass  beads  were 
used  per  gram of cells, and  homogenization  was  carried  out  in  a  medium 
Bead  Beater  chamber.  Homogenization  was  carried  out for 3 min at 30-s 
psKMHA5. 
intervals, leaving 5 min between each to allow for cooling. Cellular 
debris  and  glass  beads  were removed by  centrifugation for 10 min at 
1600 x g (4 "C). The cell debris  and  glass  beads  were  then  resuspended 
in a minimum of 10 ml of the homogenization buffer/g of cells and 
centrifuged  again as above. Both supernatant fluids  were combined and 
centrifuged for 1 h at 146,000 x g to  sediment  the  membranes.  The 
resulting  pellet  was  resuspended  in 20% (w/v) glycerol containing  50 mM 
Tris, pH 7.5, with HC1, and  0.4 mM phenylmethylsulfonyl  fluoride  and 
designated the total membrane fraction. The protein content of the 
membrane suspensions was 3-5 mg/ml. The membrane suspensions 
were divided into  aliquots  and  stored at -20 "C. 
Solubilization and Purification of the Expressed Recombinant N. 
crassa H+-ATPase-Membranes were  solubilized  with  lysolecithin at  a 
ratio of 5 mg of lysolecithidmg of membrane  protein  in a solubilization 
buffer  containing 1 mM sodium ATP/MgSO, (pH  6.8  with Tris), 0.1 mM 
Na,VO,, and 2 pg/ml chymostatin for 15  min at room temperature,  and 
the  resulting  mixture  was  centrifuged  for  10  min at 12,000 x g (23 "C) 
to sediment  the  undissolved  material.  The solubilized recombinant N .  
crassa H+-ATPase in  the  resulting  supernatant fluid  was  then  purified 
by glycerol density gradient centrifugation as described (27), on a 
smaller  scale.  Extracts from 2.2 to 2.4 mg of membrane  protein  were 
applied  to 13 ml of 2040% (w/v) linear glycerol gradients  and  centri- 
fuged for 18 h at  36,900  revolutiondmin  in  a  Beckman Ti-65 rotor a t  
4 "C. One-ml fractions  were collected. 
H+-ATPase  Assay and  Protein Estimation-The plasma  membrane 
ATPase activity  was  measured  essentially as described  (27).  The  protein 
content of the  membranes  and  gradient  fractions  was  determined by the 
Lowry procedure as modified by Bensadoun  and  Weinstein (28). 
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis, Stain- 
ing, and Immunoblotting-SDS-PAGE' was performed essentially as 
described by Laemmli  (29)  with  minor  modifications (30). Membrane 
suspensions or glycerol gradient  fractions  were mixed with  disaggrega- 
tion buffer  (50 mM Tris,  pH 6.8, with H,PO,, containing 2% SDS (wiv), 
15% glycerol (w/v), 2% p-mercaptoethanol (v/v), 1 mM EDTA, pH 6.8, 
with  NaOH,  and 0.02% (w/v) bromphenol  blue)  and  the  samples  disag- 
gregated at  room temperature for 20 min.  A  maximum of 20 p1 was 
loaded  onto  polyacrylamide  minigels  with  a 7.5% acrylamide  resolving 
gel and 5% acrylamide  stacking gel. Electrophoresis  was  routinely  car- 
ried  out  in a Bio-Rad Mini-Protean I1 electrophoresis cell. In  certain 
cases, for increased  resolution, the electrophoresis  was  carried  out in 15 
x 15 x 0.075-cm gels in a Hoefer electrophoresis cell. The gels were 
stained  with Coomassie Brilliant Blue R-250 or  silver-stained  according 
to  Morrissey (31). Immunoblotting  was  carried  out  essentially as de- 
scribed by Sarkadi  et al. (32). The antibodies used were either poly- 
clonal antibodies prepared against the N. crassa H' ATPase as de- 
scribed  (33)  using SDS-PAGE-purified H+-ATPase or polyclonal 
antibodies  against  the  cytoplasmic loops of the  yeast  PMAl H+-ATPase 
prepared as described by Capieau  et  al. (34). The  neurospora ATPase 
antibodies  were  diluted 6,000-fold, while the  yeast ATPase antibodies 
were  diluted 600,000-fold. The second antibody  used  was  anti-rabbit Ig, 
peroxidase-linked whole antibody from donkey. The  peroxidase-labeled 
blots  were developed by the  enhanced  chemiluminescence  method, US- 
ing  the  Amersham Corp. ECL  kit. 
Materials"T4-DNA  polymerase  and DNA polymerase, Klenow frag- 
ment  were  from  Promega. T4-DNA ligase, calf intestinal  alkaline  phos- 
phatase, endoglycosidase FNglycosidase F, endoglycosidase H, O-gly- 
cosidase, a-mannosidase,  and  NotI  restriction  enzyme  were  from 
Boehringer Mannheim. Ribonuclease A was from United  States Bio- 
chemical Corp. (Cleveland,  OH).  NotI  linker  (phosphorylated  10-mer) 
was  obtained from New England Biolabs. Anti-rabbit  Ig,  peroxidase- 
linked whole antibody from donkey  was  from  Amersham Life Science. 
Lithium  acetate  and  PEG 4000 were from Fluka. SDS-PAGE standards 
(low molecular  weight), Tris, and glycine, were from Bio-Rad, SDS  was 
from BDH Biochemical, and  CsCl  and  glass  beads  were from Sigma. All 
other  chemicals  used  were of analytical  grade. Oligonucleotide synthe- 
sis was  carried  out  using a Cyclone Plus DNA synthesizer  (Milliged 
Bioresearch),  and  the  polymerase  chain  reaction  was  carried  out  using 
a Perkin  Elmer 480 thermal cycler. 
RESULTS 
The yeast expression system that we have employed in these 
studies is an ingenious one developed for plasma membrane 
Hi-ATPase expression by Serrano and his colleagues (15, 22). 
The system employs a high copy number  yeast expression plas- 
mid with constitutive yeast PMAl H+-ATPase promoter and 
The  abbreviation  used  is: PAGE, polyacrylamide  gel  electrophoresis. 
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FIG. 1. Growth tests of the various yeast transformants. Panels 
A and B show drop tests of five each of the indicated yeast transfor- 
mants on plates containing galactose (GAL) or glucose (GLU), respec- 
tively, as described under "Experimental Procedures." Approximately 
lo4 cells were applied in each drop. Panels C and D show similar plates 
onto which were streaked the same amount of cells of one each of 
the various transformants as indicated. The identities of the various 
transformants are indicated in Table I and under "Experimental 
Procedures." 
transcription termination regions separated by a restriction 
site  into which is cloned the H+-ATPase cDNA  of interest.  The 
system further employs for plasmid expression a genetically 
engineered strain of S. cerevisiae, RS-72, which has  the essen- 
tial  yeast  plasma  membrane H+-ATPase under  the control of a 
genomic galactose-dependent  promoter (22). As a result,  this 
strain grows in media  containing  galactose but fails to grow for 
more than a few doublings in glucose media unless functional 
plasma membrane H+-ATPase molecules are supplied via a 
yeast expression  plasmid. With this convenient arrangement, 
functional  expression of H+-ATPase genes can be assessed by 
simple growth assays of plasmid-transformed yeast cells on 
plates  containing glucose as a carbon source. 
Fig. 1 shows the  results obtained when RS-72 cells trans- 
formed with plasmids  containing two different  forms of the N. 
crassa H+-ATPase cDNA, no H+-ATPase cDNA, the  yeast PMAl 
cDNA, and  the reverse complement of the N. crassa cDNA are 
grown on galactose or glucose media, respectively. The  names of 
the  transformed  strains,  the plasmids  used for the  transforma- 
tions,  and  the cDNAs used for the cloning are indicated in Table 
I. Five individual transformant colonies were used for each 
type of transformant. As shown in Fig. lA, all five of each of the 
five types of transformant (horizontal rows) grow well on the 
galactose medium. This indicates that none of the plasmid- 
borne cDNAs are toxic to  the RS-72 cells. As shown in Fig. lB, 
the growth characteristics of the  transformants on glucose me- 
dium are  quite different. As expected, the  transformants con- 
taining the yeast plasma membrane H+-ATPase expression 
plasmid (strain SKM4) grow well on glucose and  the  transfor- 
mants  containing a plasmid with no H+-ATPase cDNA insert 
(strain SKM3) hardly grow at all. But importantly, 9 out of 10 
of the  transformants containing  plasmids with  the N. crassa 
H+-ATPase cDNA (strains SKMl and SKM2) grow well on the 
glucose medium, and  those containing the  reverse complement 
of the H+-ATPase cDNA (strain SKM5) grow no more than  the 
plasmid control strain SKM3. These results strongly  suggest 
that the expression plasmids containing the N. crassa H+- 
ATPase cDNA are able to provide functional copies of the N. 
TABLE I 
Yeast transformants used in  this  study 
See "Experimental  Procedures"  for details. 
Name of 
transformant "asrni' used 
SKMl pSKMHAl 
sKM2 psKMHA2 N. crussu H+-ATPase 
SKMB pRS421Not None 
sKM4 pPS15P1 
SKMB 
S. cereuisiae H+-ATPase 
psKMHA5 Antisense N. crassa H+-ATPase 
cDNA used 
N. crassa H+-ATPase 
crassa H+-ATPase, which in  turn  support  the growth of the 
yeast cells. 
Figs. 1, C and D, show the  results obtained  when one each of 
the five types of transformants were  plated on galactose and 
glucose media in a manner that more clearly indicates the 
growth rates of individual transformed cells as reflected by 
colony size. Although only growth on plates is shown, similar 
results were  obtained  with liquid culture growth  experiments 
(not shown). As above, each of the  transformants grows well  on 
the galactose  medium. The growth rates of each of the types of 
transformant on galactose  medium are similar, which probably 
reflects the fact that  they  all  have  an  adequate supply of the 
yeast PMAl H+-ATPase supplied via the genomic galactose- 
dependent promoter. The  results obtained  with the glucose me- 
dium are also similar. Strains SKM3 and SKM5 fail to grow 
detectably whereas  strains SKM1, SKM2, and SKM4 all ex- 
hibit  substantial growth. In  this case, however, differences in 
the growth rates of the individual transformants  are clearly 
evident. Strain SKM4 with the  yeast H+-ATPase construct ex- 
hibits  the  greatest growth rate, followed by strains SKMl and 
SKMB containing the N. crassa H+-ATPase constructs. The 
growth of strain SKM4 on glucose medium is even faster  than 
that on galactose medium which may reflect more efficient 
expression of the  yeast H+-ATPase via the constitutive pro- 
moter, the  activating effect of glucose on the  yeast H+-ATPase 
activity (12,351, or a general preference of the cells for glucose 
as a carbon source. Strain SKMl likewise exhibits a higher 
growth rate on glucose medium. It  is  interesting  that  strain 
SKM4 which contains the  yeast H+-ATPase cDNA in a low  copy 
number plasmid grows better  in glucose medium than  either 
strain SKMl or SKMB which contain the N. crassa H+-ATPase 
cDNA in a high copy number plasmid. This may reflect a 
preference of yeast cells for their own plasma membrane 
H+-ATPase, which would not  be  surprising. Fig. 1D also clearly 
shows that  strains SKMl and SKM2, which contain plasmids 
with only very  minor differences in  the bases preceding the N. 
crassa H+-ATPase cDNA sequence,  vary significantly in  their 
growth rates.  This will be mentioned again below. 
The most straightforward interpretation of the results of 
these growth experiments  is  that  the N. crassa plasma mem- 
brane H+-ATPase can be readily  synthesized in functional form 
in S. cereuisiae. In  order  to  test  this possibility more directly, 
crude membranes were isolated from the various transfor- 
mants, and the presence of the N .  crassa H+-ATPase was 
probed by minigel SDS-PAGE and Western blotting. Fig. 2 
shows the  results of these experiments. Because the available 
antiserum to the N. crassa H+-ATPase cross-reacts to some 
extent  with  the S. cereuisiae H+-ATPase, it was  first necessary 
to analyze the  content of the S. cerevisiae H+-ATPase in  the 
various strains  after growth in galactose or glucose medium 
before the  extent of expression of the N. crassa H+-ATPase 
could be  ascertained. This  was  made possible by the  use of an 
S. cereuisiae H+-ATPase polyclonal antiserum at a dilution in 
which it fails  to  substantially  interact with the N. crassa H+- 
ATPase. Fig. 2.4 shows the  results of a representative experi- 
ment of this kind. Lane 9 contained 20 ng of purified N. 
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FIG. 2. Western blot analyses of membranes isolated from 
yeast transformants grown on galactose or glucose media. The 
cells were grown to  saturation  in  galactose  medium,  diluted 10-fold into 
either  galactose (GAL) or glucose (GLU) medium, allowed to grow for 
an additional 24 h at 30 “C, and  then  used for membrane  preparation as  
described under “Experimental Procedures.” Western blots of SDS- 
PAGE analyses of total  membranes  (2  gg of proteidane) were  then 
camed  out as described under ”Experimental Procedures.” Panel A 
cereuisiae PMAl H+-ATPase diluted 1:600,000. Panel B shows a blot 
shows a blot using a polyclonal antiserum directed against the S. 
using  a polyclonal antiserum  directed  against  the N. crassa H+-ATPase 
a t  a  dilution of 1:6000. Lanes 1 and 5, membranes from strain SKM1; 
lanes 2 and 6, membranes from strain SKM2; lanes 3 and 7, membranes 
from strain SKM3; lanes 4 and 8, membranes from strain SKMC; lane 
9, 20 ng of purified N. crassa H+-ATPase isolated from N. crassa.  Only 
the -100 kDa region of the blots are shown. No antibody-reactive  ma- 
terial of interest was seen  elsewhere  in the blots. 
crassa H+-ATPase which was barely recognized by the  yeast 
H+-ATPase antiserum.  Thus,  the majority of the antibody-re- 
active material  seen  in  the various lanes of Fig. 2A represents 
the  yeast H+-ATPase. Lanes 3 and 7 represent exclusively the 
yeast H+-ATPase, as  they contained  disaggregated membranes 
from strain SKM3, the control strain  with no plasmid-borne 
H+-ATPase. Lane 3,  with  membranes from cells grown on ga- 
lactose  medium, establishes  the  regular level of expression of 
the  yeast H+-ATPase supplied to  the cells via the genomic ga- 
lactose-dependent promoter. Lane 7 shows that when strain 
SKM3 grown on galactose medium is transferred to glucose 
medium, the  amount of the  yeast H+-ATPase substantially de- 
creases. As explained by Villalba et al. (151, this is because 
galactose-dependent synthesis of the H+-ATPase ceases in glu- 
cose medium, and  the H+-ATPase is then  diluted by continued 
growth of the cells until  the  supply of the H+-ATPase reaches an  
intolerably low level upon which cell growth is  arrested. Lane 4, 
with membranes from strain SKM4, establishes  the level of 
yeast H+-ATPase expression in cells receiving copies of the 
ATPase directed from both the galactose-dependent genomic 
promoter and  the plasmid-borne  constitutive PMAl promoter. 
Lane 8 shows the  amounts synthesized only via the expression 
plasmid. Lanes 1 and 2 show that  membranes from the two 
strains  bearing  the N. crassa H+-ATPase expression  plasmids 
grown on galactose  contain roughly the  same  amount of yeast 
H+-ATPase as the expression plasmid control (lane 3) ,  and 
these levels substantially decrease after  transfer of the cells to 
glucose medium (lanes 5 and 6) .  The amounts of the yeast 
H+-ATPase present  in lanes 5 and 6 are  in fact  much less  than 
that  seen  in lane 7 because the cells giving rise  to lanes 5 and 
6 underwent more doublings and  resultant  yeast H+-ATPase 
dilution, than  those giving rise  to lane 7. As will be  shown  next, 
the antibody reactive material in lanes 5 and 6 is predomi- 
nantly  the N. crassa H+-ATPase expressed in  amounts  greater 
than  the 20-ng detection limit shown in lane 9. 
With this preliminary analysis,  the  results of Western  blots 
using  the N. crassa H+-ATPase polyclonal antibody (Fig. 2B) 
are readily interpreted. Lanes 5-7 show the  amount of antibody 
reactive material  present  in  membranes from cells of the N. 
crassa H+-ATPase plasmid-bearing strains SKMl and SKMS, 
and  the plasmid control, SKM3, respectively, after  the  transfer 
of galactose-grown cells into glucose medium and overnight 
growth. As explained above, the  amount of antibody-reactive 
material  present  in lane 7 establishes  the maximum amount of 
the  yeast H+-ATPase that  can be present  in lanes 5 and 6, and 
the  actual  amount  is  substantially less. Therefore, the  great 
SKMl 5’- CTCGAAGCGGCCGCTGATCCCTrnGCGGA- 3’ 
SKMZ 5” CTCGAAGCGGCCGCTGATCCAATaGCGGA- 3’ 
strains SKMl and SKM2. Shown are  the  bases near  the ATG start 
FIG. 3. 5”Upstream sequences of the cDNAs used to generate 
codons (underlines at   the  right 1 of the N. crassa H+-ATPase cDNAs that 
were  used  to  generate the plasmids that produced strains  SKMl  and 
SKM2. The left underlines indicate  the  remnant  bases of the XhoI site 
of plasmid  pRS421 that  was lost upon the introduction of a Not1 site as 
described  under  “Experimental  Procedures.” 
majority of the antibody  reactive material  seen  in lanes 5 and 
6 represents  the N. crassa H+-ATPase. Comparison of the  in- 
tensity of the  bands  seen  in lanes 5 and 6 to  that of the 20-ng 
N. crassa H+-ATPase standard (lane 9 )  indicates  that  the N. 
crassa H+-ATPase is expressed in  strains SKMl and SKMB at 
levels several  percent of the  total  membrane protein, since 2 pg 
of membrane protein  was loaded in each well. 
Although not as striking, a similar  analysis of the Western 
blots of membranes from the various transformants grown in 
galactose  medium (Fig. 2, A and B ,  lanes 1 3 )  indicates that 
significant amounts of the N. crassa H+-ATPase are  synthe- 
sized in  strains SKMl and SKMB when grown on galactose, as 
expected. 
The difference in  the  amounts of the N. crassa H+-ATPase 
expressed in  strains SKMl and SKM2 grown on glucose (Fig. 
2B, lanes 5 and 6 )  is noteworthy. The  amount of the H+-ATPase 
made  in  strain SKMl is several times  greater  than  that  made 
in  strain SKMB when membranes from cells grown in glucose 
medium for 24 h are examined. This correlates well with the 
significantly greater growth rate of strain SKMl relative  to 
strain SKMS in glucose medium and  supports  the idea that  the 
growth rate of these cells is dictated by their supply of the N. 
crassa H+-ATPase. Fig. 3 shows the sequences of the yeast 
expression vectors used to  generate  strains SKMl and SKMB in 
the only region where they differ, just  upstream from the N. 
crassa H+-ATPase ATG start codon. The  substantial decrease in 
the amounts of the H+-ATPase synthesized in strain SKM2 
relative  to  strain SKMl is  apparently  due solely to  the  substi- 
tution of two As for a C a t  position -2 from the ATG start codon. 
Interesting additional differences between the N. crassa H+- 
ATPase molecules produced in SKMl and SKM2 cells and  the 
yeast H+-ATPase molecules produced in SKM3 and SKM4 cells 
are revealed when the  membranes from the various  transfor- 
mants  are subjected to  higher resolution SDS-PAGE and  ana- 
lyzed by Western blotting. Fig. 4 shows the  results of such an 
experiment. The  yeast ATPase produced from the genomic DNA 
in  strain SKM3 during growth  in  galactose  medium and  then 
subsequently diluted during growth in glucose medium ap- 
pears as a barely visible band  in  the 100 kDa region (lane 3 )  
migrating slightly but reproducibly above that of the N. crassa 
H+-ATPase standard (lane 5 ) .  The  yeast H+-ATPase produced 
from the expression  plasmid during growth on glucose migrates 
in  the  same position (lane 4) .  The N. crassa H+-ATPase pro- 
duced in SKMB cells (lane 2 )  migrates a t  a position identical to 
that of the N. crassa H+-ATPase standard, as might be ex- 
pected. But interestingly, the majority of the N. crassa H+- 
ATPase produced in SKMl cells migrates in a position slightly 
higher  than  the  yeast H+-ATPase and  substantially higher than 
the N. crassa H+-ATPase standard. Only a small  fraction of the 
N. crassa H+-ATPase migrates to a position similar to that 
isolated from neurospora cells. Analyses of similar gels stained 
with  silver indicate  that  the difference in  the molecular masses 
of the neurospora ATPase molecules produced in  strains SKMl 
and SKMB is  apparently  about 6000 daltons.  Essentially iden- 
tical results were obtained with membranes prepared from 
each of the four clones of SKMl and each of the five clones of 
SKM2 that grow in glucose medium  (Fig. 1). 
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from strains SKM1, SKM2, SKMB, and SKMQ. Membranes from the 
FIG. 4. High resolution Western blot analysis of membranes 
respective  yeast  transfornxlnts ( 1  ug of protcinflane)  were  subjected  to 
large gel SDS-PAGE and Western blotting using the N. crassn H’- 
ATPase antiserum as described  under  “Experimental  Procedures.”Lnne 
1, SKi1 membranes: Inn(. 2. SKU2 membranes; lane 3 ,  SKM3 mem- 
branes; lune 4 ,  SKM4 membranes; Inne 5 ,  5 ng of purified native N. 
crn.ssa H’-ATPase. 
A variety of experiments  have  been  carried  out  in  an  effort  to 
explain the anomalous mobility of the H+-ATPase molecules 
expressed  in  strain SKM1. Restriction  analysis of the  transfor- 
mation  plasmids  reisolated  from  strains  SKM1, SKMB, SKM3, 
and SKM4 by the  procedure of Hoffman  and  Winston  (36)  and 
amplified  in Escherichia coli indicated  that  the  reisolated  plas- 
mids  were  identical  to  those  used for the  transformations  (not 
shown),  which  rules  out a major  unexpected  genetic  rearrange- 
ment  in  any of the  plasmids.  Likewise, a Southern  blot  analysis 
of HindIII  digests of the genomic DNA of strains SKM1, SKM2, 
SKM3, and RS-72 using the yeast PMAl cDNA as a probe 
indicated  that  the  genomic  12.5-kilobase  HindIII PMAl frag- 
ment of RS-72  (22)  was  unchanged  in  the  transformants,  ruling 
out  major  genetic  rearrangements  in  the PMAl gene.  The  fact 
that the  transformation efficiencies were  essentially  the  same 
for strains SKM1, SKMB, and SKM3 (data not shown) also 
argues  against  genetic  rearrangements  in  these  strains.  Fur- 
thermore,  treatments of the SKMl and  SKM2  membranes  and 
the  purified  expressed  H+-ATPase  molecules  therefrom  (see be-
low)  with calf intestinal  alkaline  phosphatase,  endoglycosidase 
F/N-glycosidase F, endoglycosidase  H,  0-glycosidase,  or  a-man- 
nosidase by published  procedures  had  no effect on  either of the 
ATPase molecules, suggesting that differential phosphoryla- 
tion or glycosylation of the  H+-ATPase  in  strains SKMl and 
SKM2 does not occur. Staining of SDS-PAGE gels by the 
periodate/dansyl hydrazine procedure (37) does suggest that 
the neurospora H+-ATPase molecules in strains SKMl and 
SKM2 are glycosylated  to  some  extent,  but  the  extent of glyco- 
sylation  is  about  the  same for both  (data  not  shown). 
As another explanation of the anomalous mobility of the 
SKMl ATPase molecules, we considered the possibility tha t  
translation initiation occurs in strain SKMl at an in-frame 
start codon upstream  from  the  neurospora  ATPase ATG start 
codon. To test this possibility, plasmid  pSKMHAl  was  digested 
at the Not1  site  just  before  the  ATPase start codon, filled-in 
with Klenow, and  religated,  which  introduced  four  new  bases 
and  shifted  the  reading  frame of the  ATPase cDNA relative  to 
the  yeast  promoter  region.  When  this  altered  plasmid  was  used 
to  transform  the  yeast  cells,  the  ATPase  produced  was  the  same 
size as tha t  produced in strain SKMB and the native neuro- 
spora enzyme. Thus, the neurospora H+-ATPase produced in 
strain  SKMl  may well have  an  unanticipated  N-terminal  ex- 
tension. 
The  next  important  question f interest  regards  the  function- 
ality of the N. crassa H+-ATPase molecules synthesized in  
strains SKMl and  SKM2.  The  fact  that  these  strains  grow  in 
glucose medium indicates that some of the N. crassa H+- 
ATPase  molecules that  are  synthesized  in  these  cells  must  be 
functional.  But  this  does  not  indicat,e  the efficiency with  which 
functional  ATPase  molecules  are  produced, i.e. whether  or  not 
the  majority of the ATPase  molecules  produced are  functional. 
Table I1 shows  the  results of several  experiments  in  which  the 
ATPase  activities of membranes  prepared  from  strains SKM1, 
T:w.r I1 
H-ATPase actiuify of metnhrnrles isolnted from strnim 
SKMI, SKM2. and SKM3 
The  data  represent  the  results of experiments  measuring  the ATPase 
activity in membranes  isolated from cells grown with glucose as  a car- 
bon source for 24 h  as described under  “Experimental Procedures.” The 
Roman numerals indicate two separate experiments carricd out on 
direrent days.  The  entries  represent  the  average of duplicate  determi- 
nations. 
ATPase activity 










0.247 0.042 0.205 
SKMS 
0.138 0.042 0.096 
I 0.090 0.016 0.074 
I1 
SKMB 
0.068 0.025 0.043 
I 0.050 0.021 0.029 
Strain -”
SKM2, and SKMS grown in glucose medium for 24 h were 
measured  using  our  standard  assay  for  the  N. crassa 
Hi-ATPase activity. The vanadate-inhibitable fraction of the 
total  ATPase  activity is a reflection of the  amount of functional 
plasma  membrane  H+-ATPase  molecules  present  in  the  mem- 
branes.  The  values  obtained  parallel  the  antibody  staining  in- 
tensities of the Western blots shown in Fig. 2B, lanes 5-7. 
Membranes  from  strain  SKMl  have  the  greatest  amount of the 
N .  crassa H+-ATPase  and  exhibit  the  highest l vel of vanadate- 
sensitive  ATPase  activity.  Strain  SKM2  membranes  are a few 
fold less  in  both  categories.  Similar  results  were  obtained  with 
membranes  from  all of the other  clones of strain SKMl and 
SKM2 that grow  on  glucose  medium.  As  expected,  the  control 
strain SKM3 has even lower amounts of vanadate-sensitive 
ATPase activity. Rough estimates of the amounts of the N. 
crussa H+-ATPase molecules in the membranes from strains 
SKMl  and  SKM2  based on protein  staining of SDS-PAGE gels 
indicates that the specific activities of the N. crassa H-ATPase 
in  these  membranes  are  similar  to  that of the  enzyme  in  its 
native  membrane. 
In  order  to  address  this  question  even  more directly, mem- 
branes from strains SKMl and SKM2 were solubilized with 
lysolecithin,  and  the  resulting  extracts  were  subjected  to glyc- 
erol density gradient centrifugation. When N. crassa mem- 
branes  are  treated  in  this  manner,  the  H+-ATPase  migrates  to 
a position  near  the  bottom of the  gradient  in  nearly  pure form 
(27, 38). The  relatively  rapid  migration of the  ATPase  in  such 
gradients  occurs  because i t  is  present  in  the  lysolecithin  extract 
as a well-defined hexamer of 100-kDa  monomers (39). Fig. 5, A 
and  B,  show  the  results of such an  experiment  with SKMl and 
SKMB membranes, respectively. The  SKM2  cells  were  grown 
for 48 h in glucose medium. In comparison with 24 h SKM2 
cultures,  this  further  dilutes  the  yeast  H+-ATPase  content of 
the  membranes  and  also  significantly  increases  the  amount of 
the  neurospora  H+-ATPase  relative  to  the  other  membrane pro- 
teins.  It  can  be  seen that the  ATPase  molecules  solubilized from 
either SKkll or SKMB membranes  migrate  to a  position in  the 
gradient  essentially  identical  to  that  seen  for  the  native  neu- 
rospora enzyme (38). The recombinant H-ATPase molecules 
are also  substantially  purified  in  the  process,  since  the  majority 
of the  protein  applied  remains  near  the  top of the  gradient. In 
both  cases,  the  purified  ATPase  is  inhibited  almost completely 
by vanadate.  The  Western  blot  in  the inset of Fig. 5A confirms 
the  presence of the N. crassa H+-ATPase  in  the  lower  gradient 
fractions  and  shows  that  the great majority of the  expressed 
enzyme applied to the gradient is present in an oligomeric 
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FIG. 5.  Glycerol density gradient purification of the N. crassa 
H+-ATPase expressed in stains SKMl and SKMS. Membranes from 
strain SKMl grown in glucose media for 24 h ( panel A )  or from strain 
SKM2 grown for 48  h (panel B )  were solubilized with lysolecithin and 
subjected  to glycerol density  gradient  centrifugation as  described  under 
“Experimental  Procedures.”  Plotted  are  the  protein  contents (0) and  the 
ATPase activities  in  the  absence (3) and  presence (A) of 100 pkl vana- 
date of the gradient fractions. Fractions 1 came from the top of the 
gradients.  The inset in panel A shows  a  Western blot analysis of the 
respective  gradient  fractions  using  the  anti-neurospora H+-ATPase 
antiserum. 
form, presumably  a  hexamer. Only small amounts of the H+- 
ATPase were found in the  material pelleted at  the bottom of the 
gradient tubes. Although not shown,  Western blot analyses of 
the  gradient fractions in  the experiment of Fig. 5B gave similar 
results. This experiment has been carried out several times 
with  essentially  identical results each time. A similar control 
experiment with membranes from strain SKM3 grown in glu- 
cose medium for 24 h showed a similar  distribution of mem- 
brane protein, but  the  yeast H+-ATPase activity was below the 
limit of detection of the ATPase assay in the various gradient 
fractions. 
Fig. 6A shows a silver-stained high resolution SDS-PAGE 
analysis of the SKMl membranes (lane 1 )  and the pooled 
peak glycerol gradient fractions (lane 2 )  from the experiment 
of Fig. 5A. Densitometric analysis of lane 1 of this figure  indi- 
cated that  the expressed N .  crassa H+-ATPase (left arrow) con- 
stitutes about 4% of the SKMl membrane protein,  in  line  with 
the  results of Fig. 2B. Densitometric analyses comparing lane 
A. 6. 
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FIG. 6. SDS-PAGE analysis of SKMl and SKM2 membranes  and 
the pooled peak glycerol gradient fractions from the experi- 
ments of Fig. 5. Panel A, SKhfl membranes (lane 1, 1 pg of protein) 
experiment of Fig. 5A were subjected  to  large gel SDS-PAGE and  silver 
and 5 pl of the pooled glycerol gradient  fractions 10-12 (lane 2 )  from the 
tained 5 ng of purified native N. crassa H’-ATPase. Panel B,  SKM2 
staining  as described under  “Experimental  Procedures.” Lane 3 con- 
gradient  fractions 10-12 (lane 2 )  from the  experiment of Fig. 5B were 
membranes (lane 1, 2  pg of protein)  and  10 pl of the pooled glycerol 
analyzed as described for panel A. Lane 3 contained 5 ng of purified 
native N. crassa H+-ATPase. The num.bers indicate  the  molecular 
masses of the SDS-PAGE standards used in kDa and apply to both 
panels A and B. See  text for the definitions of the arrows. 
2 of this figure and lane 3, which contained 5 ng of purified 
native N. crassa H+-ATPase (right  arrow), allowed the calcula- 
tion of a specific activity of roughly 50 pmol of  ATP 
hydrolyzedmg of ATPase proteitdmin for the expressed 
ATPase in the glycerol gradient fractions, which is comparable 
to  the  highest specific activity  ever measured in this labora- 
tory for the purified native N. crassa H+-ATPase. Fig. 6B 
shows a similar  analysis of the SKM2 membranes  and glyc- 
erol gradient fractions from the experiment of Fig. 5B. Densi- 
tometric analyses of the SKM2 membranes  and glycerol gradi- 
ent fractions  indicated that  the H+-ATPase in SKM2 
membranes from 48-h cultures (left arrow) constitutes  about 
2% of the  total  membrane protein and  that  the specific activ- 
ity of the purified SKMP ATPase is also about 50. These re- 
sults  thus indicate that  in both strains SKMl and SKMS, the 
N. crassa H+-ATPase is expressed in very high amounts,  that 
it  folds properly enough to be able to  assume  its hexameric 
quaternary form upon solubilization with lysolecithin, and 
that upon purification by  glycerol density gradient centrifuga- 
tion it  is fully functional  with  respect to ATP hydrolysis. 
DISCUSSION 
The  results  presented in this  paper  mark  the end of a long 
search  in this laboratory for a suitable expression system for 
the neurospora  plasma membrane H+-ATPase. The value of the 
site-directed mutagenesis approach to  understanding enzyme 
mechanisms is widely appreciated, and recent  encouraging re- 
sults of efforts to crystallize the N. crassa H+-ATPase (16) have 
made the need for an effective H+-ATPase expression system 
even more essential.  In  the  last several years, we have  thus 
tried many different systems for expressing the neurospora 
H+-ATPase, which is  partially reflected in the somewhat circui- 
tous  route by which the  yeast expression plasmids  used  in the 
current  study were produced. We began with  several attempts 
to express the H+-ATPase in E. coli. Of these, the T7 RNA 
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polymerase/promoter system of Tabor and Richardson  (20) pro- 
duced the  greatest  amounts of the ATPase, but  it  was exten- 
sively proteolyzed, even in  strains of E.  coli with reduced pro- 
tease activity. Attempts to  produce stable  transfectants 
expressing  the H+-ATPase in NIH  3T3 cells via the eukaryotic 
expression vector pKC4 (40)  were unsuccessful. We also tried a 
transient expression system  in COS cells similar  to  that used 
for the Ca2+-ATPase of sarcoplasmic  reticulum by MacLennan 
and  his colleagues (41). Whereas  the H+-ATPase was  expressed 
in  this  system,  the levels of expression  were too low to  permit 
facile assays of the expressed H+-ATPase activity, and  the  re- 
agents were  relatively expensive. We next turned  to  the 
baculovirudinsect cell system  (42)  and obtained an  astonishing 
level of H+-ATPase expression of roughly one-third of the  total 
insect cell membrane protein. Unfortunately, the H+-ATPase 
produced in  this  system  was  totally dysfunctional. It failed to 
fold properly enough to  migrate as a hexamer  in glycerol den- 
sity  gradients  after solubilization in lysolecithin (38,39),  and  it 
was completely devoid of ATPase activity. This discouraging 
experience brought to  light  the possible need for an  intracellu- 
lar environment conducive to  the proper folding andor proc- 
essing of the H+-ATPase molecule, which pointed to  yeast as a 
possible expression organism, owing to its evolutionary relat- 
edness  to  neurospora.  The  results were positive from the  out- 
set,  and as described in  this paper, establish s. cereuisiae as  the 
organism of choice for the expression of recombinant N. crassa 
H+-ATPase molecules. 
Several  features of the  yeast expression  system for the N. 
crassa H+-ATPase are worthy of emphasis.  First,  the  system  is 
economical, requiring only standard cloning reagents  and  in- 
expensive growth media. Second, the generation of site-di- 
rected  mutants should be relatively fast,  requiring only cloning 
in E. coli and  transformation of yeast cells with  the  resulting 
plasmids. The availability of a  growth test for functional  H+- 
ATPase molecules (Fig. 1) should be especially useful in  this 
regard.  Third,  the  amounts of functional N. crassa H+-ATPase 
produced are very large, allowing for thorough biochemical 
analysis of the  mutants produced. Fourth,  the expressed 
ATPase molecules are readily solubilized and purified by our 
standard techniques. This should allow facile reconstitution by 
our  standard methodology and  assessment of the proton trans- 
locating characteristics of the mutants produced. Moreover, 
this  makes  quite feasible the possibility of obtaining  crystals of 
the recombinant mutant forms of the H+-ATPase by our newly 
developing H+-ATPase crystallization methodology (16). And 
finally, the  fact  that  the recombinant N. crassa H+-ATPase mol- 
ecules  expressed in S. cereuisiae migrate  to a position essen- 
tially identical to  the  native enzyme after  detergent solubiliza- 
tion and glycerol density  gradient centrifugation provides us 
with a powerful assessment of the ability of the recombinant 
H+-ATPase molecules to  fold properly. Utilizing this assay, site- 
directed ATPase mutants  that  are inactive  because they fail to 
fold properly  upon synthesis should be readily discriminated 
from those  that fold properly and  are inactive for more inter- 
esting reasons. 
Whereas this system has many advantages, two potential 
caveats  regarding  its  use should be mentioned. First, site-di- 
rected ATPase mutants  that  are  totally devoid of activity will 
fail to  support  the growth of their  host  yeast cells, at least 
under  the growth conditions used for these experiments. In  the 
absence of cell growth, the endogenous yeast ATPase could 
represent a significant contaminant of the expressed mutant N. 
crassa H+-ATPase molecules. Whether or not this will prove to 
be a problem will depend to a large extent on the levels of 
production of the recombinant H+-ATPase molecules relative  to 
that of the  yeast H+-ATPase remaining when the cells stop 
growing, but  attention  to  this potential problem is prudent. A 
second caveat arises from the  apparent potential for repair of 
the H+-ATPase expression  plasmids to produce unexpected re- 
sults (24). Frequent checks of the expression plasmids re- 
isolated from yeast by restriction site analysis, as was done 
here,  and by sequencing of the  mutated region of important 
mutant plasmids recovered from the  yeast cells, will hopefully 
prevent  any problems in  this  regard. 
As suggested by Villalba et al. (151, the yeast expression 
system  used in  these  studies is of great  potential value for the 
heterologous  expression of other  integral  membrane proteins. 
We have recently become interested  in several  eukaryotic in- 
tegral membrane proteins involved in human disease states 
(32,  43) and, encouraged by the  results  presented  here,  are  in 
the process of exploring the expression of these genes in yeast. 
The differences we have noted in  the levels of expression of the 
N. crassa H+-ATPase in  strains SKMl and SKM2 may be im- 
portant  to keep in mind in  this  regard. At the  outset of these 
studies, we noted that  the N. crassa H+-ATPase cDNA as it has 
evolved in  our  laboratory  has  cytosine at position -3 from the 
ATPase ATG start codon, and it has been pointed out  that most 
yeast genes, particularly highly transcribed ones, have an 
adenosine at  this position (44, 45). We therefore  engineered  a 
N. crassa H+-ATPase cDNAwith  a  -3Ain the hopes of obtaining 
a higher level of H+-ATPase expression. Because the S. cereui- 
siae H+-ATPase has CAAT preceding the ATG start codon, we 
made  the N. crassa H+-ATPase clone with a CAAT preceding 
the ATG start codon, which also  preserved a desirable BamHI 
site. This had  the  result of also  introducing an  extra A in  this 
clone relative  to  the plasmid  used to produce strain SKMl (Fig. 
3). As can be seen in Figs. 1, 2, and 4, and Table 11, these 
seemingly  innocuous changes  in  the  bases  just  upstream from 
the neurospora ATPase ATG start codon resulted in rather 
marked differences in  the level of expression of the H+-ATPase 
molecules. However, the levels of expression  were opposite that 
expected, with  the -3C clone producing substantially higher 
levels than the -2AA clone. Subsequent studies described 
above suggest that  the  higher level of ATPase expression in 
strain SKMl may be due to initiation at an in-frame start 
codon upstream from the neurospora ATPase start codon, 
which does not occur in  strain SKM2 because of the frameshift 
produced by the  extra A. These results  thus suggest that spe- 
cial attention should be paid to  the  bases immediately preced- 
ing  the coding sequence  when planning  strategies for express- 
ing new genes in this and possibly other yeast expression 
systems. 
As shown in Figs. 4 and 6 ,  the N. crassa H+-ATPase mol- 
ecules  expressed in  strain SKM2 migrate  in  an SDS-PAGE  gel 
to  the  same position as  the  native nzyme. It  is therefore likely 
that  the recombinant N. crassa H+-ATPase molecules expressed 
in  yeast  strain SKMB are essentially  identical to those present 
in N. crussa. However, the majority of the N. crassa H+-ATPase 
molecules expressed in yeast strain SKMl reproducibly mi- 
grate  to a higher position in  such gels. This  anomalous behavior 
of the SKMl N. crassa HI-ATPase molecules does not appear to 
be due  to genetic rearrangements, phosphorylation, or several 
types of glycosylation. Rather,  as mentioned above, it  appears 
to be due to  initiation of translation  at  an u expected upstream 
start codon, since a frameshift  just  upstream from the neuro- 
spora ATG start codon eliminates  the anomalous behavior. The 
DNA sequence 180 bases  upstream from the neurospora H+- 
ATPase start codon in plasmid pSKMHAl does not  contain any 
in-frame ATG start codons. However, it does contain an up- 
stream in-frame ATT that is not followed by a termination 
codon and  that  is not present  in pSKMHA2 due  to  the  insertion 
of the  extra A. Translation  initiation at  this codon would prod- 
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uce a fusion  protein about  the size of that produced in  strain 
SKM1. Although there is precedent for occasional initiation at 
ATT codons in  eukaryotes (46,471, more work will be needed to 
substantiate  this  interpretation.  It should be noted, however, 
that  whatever  the reason is for the anomalous mobility of the 
SKMl H+-ATPase molecules, it has no obvious deleterious ef- 
fect on their function, since they fold properly and  are at least 
as active as their  natural  counterpart. 
In summary, following the  lead of Villalba et al. (E), we have 
developed an experimentally facile expression system for pro- 
ducing the neurospora plasma  membrane H+-ATPase in high 
yields in fully functional form in S. cereuisiae. The techniques 
described offer the additional advantage of an  assessment of 
the  extent  to which the expressed H+-ATPase molecules have 
properly folded, a feature  that  is  not available for most integral 
membrane protein  expression  systems. With this system, we 
are now equipped to begin efforts to identify  amino acid resi- 
dues in the H+-ATPase important for catalytic activity and 
other critical H+-ATPase functions. The knowledge obtained 
from these  studies should be useful in  their own right  and of 
even greater value when information as to  the  three-dimen- 
sional structure of the H+-ATPase becomes available. 
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